You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
*近日，《医药经济报》刊发安斯泰来副总经理及大中华区政府事务及商务本部总监张鸿先生的署名文章，全文如下：...
在2023年第19届年度世界研讨会上公布数据 2023年2月24日，东京 -...
Read more about 安斯泰来宣布研究性AT845在治疗晚发型庞贝氏症成人患者的FORTIS临床实验研究的最新初步安全性和疗效数据
东京，2023年2月13日——安斯泰来制药公司(TSE:...
Follow China news
